Hennion & Walsh Asset Management, Inc. Amneal Pharmaceuticals, Inc. Transaction History

Hennion & Walsh Asset Management, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 20, 2023	SELL	$1.27 - $2.7 $2,198 - $4,673	-1,731 Reduced 3.2%	52,339 $73,000
Q4 2022 Jan 12, 2023	SELL	$1.96 - $2.61 $15,425 - $20,540	-7,870 Reduced 12.71%	54,070 $108,000
Q3 2022 Nov 14, 2022	SELL	$2.02 - $3.62 $6,431 - $11,526	-3,184 Reduced 4.89%	61,940 $125,000
Q2 2022 Jul 19, 2022	SELL	$3.01 - $4.46 $2,784 - $4,125	-925 Reduced 1.4%	65,124 $207,000
Q1 2022 Apr 26, 2022	SELL	$3.9 - $4.89 $17,409 - $21,828	-4,464 Reduced 6.33%	66,049 $275,000
Q4 2021 Feb 14, 2022	BUY	$3.95 - $5.85 $6,312 - $9,348	1,598 Added 2.32%	70,513 $338,000
Q3 2021 Nov 12, 2021	BUY	$4.31 - $5.64 $89,410 - $117,001	20,745 Added 43.07%	68,915 $368,000
Q2 2021 Aug 13, 2021	BUY	$5.12 - $6.82 $246,630 - $328,519	48,170 New	48,170 $247,000

183

141M

57K

49K

Ticker AMRX
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 151,408,992
Market Cap $1.21B
Description
Amneal Pharmaceuticals, Inc., together with its subsidiaries, develops, licenses, manufactures, markets, and distributes generic and specialty pharmaceutical products for various dosage forms and therapeutic areas. The company operates through three segments: Generics, Specialty, and AvKARE. The Generics segment develops, manufactures, and comme...

Get notified when there are updates to the investment portfolio of Hennion & Walsh Asset Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Hennion & Walsh Asset Management, Inc. with notifications on news.